Magnetic resonance guided high intensity focused ultrasound (MRgFUS) can be used for focal therapy of prostate cancer. After treatment, these men remain in active surveillance. Effective monitoring of these men requires an understanding of the expected MRI appearance of the prostate after MRgFUS. Twenty-three patients treated with MRgFUS for focal, intermediate risk MR imaging-visible prostate cancer were followed with serial MRI for 6-24 months. We describe temporal changes in the qualitative and quantitative multiparametric imaging features of the prostate gland post-MRgFUS ablation to aid radiologists to better interpret follow-up examinations to detect residual or new disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords